ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,377Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 3647

$1.47M Total Retail Price of All Prescriptions

Rank: 81 out of 3647

1,217 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,217 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 1,217 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 20,905 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 1,369 1,046 1 4
OMEPRAZOLE 1,274 886 2 3
LEVOTHYROXINE SODIUM 896 721 3 5
PRAVASTATIN SODIUM 886 713 4 16
AMLODIPINE BESYLATE 834 632 5 2
SIMVASTATIN 754 583 6 1
MELOXICAM 642 518 7 33
LOSARTAN POTASSIUM 616 484 8 11
METFORMIN HCL 580 402 9 6
HYDROCODONE-ACETAMINOPHEN 564 300 S3 10 12
LOVASTATIN 534 416 11 21
METOPROLOL TARTRATE 530 420 12 7
HYDROCHLOROTHIAZIDE 530 388 12 9
ATENOLOL 494 422 14 10
GABAPENTIN 476 325 15 17
METOPROLOL SUCCINATE 456 351 16 18
FUROSEMIDE 381 255 17 8
TRAMADOL HCL 295 160 18 22
GLIPIZIDE ER 286 204 19 112
PREDNISONE 284 217 20 43
WARFARIN SODIUM 283 246 21 15
CIPROFLOXACIN HCL 283 192 21 53
POTASSIUM CHLORIDE 283 197 21 24
ALENDRONATE SODIUM 282 227 24 23
GLIPIZIDE 276 206 25 41
AMITRIPTYLINE HCL 268 179 R 26 105
FLURBIPROFEN 256 230 10 27 483
PANTOPRAZOLE SODIUM 251 171 28 38
CLOPIDOGREL 247 185 29 26
PROAIR HFA 239 147 30 62
CITALOPRAM HBR 236 145 31 25
ISOSORBIDE MONONITRATE ER 224 153 32 56
ZOLPIDEM TARTRATE 223 124 33 14
ATORVASTATIN CALCIUM 221 159 34 13
TIZANIDINE HCL 221 168 34 126
GLIMEPIRIDE 221 157 34 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 217 175 37 36
DONEPEZIL HCL 216 189 38 30
ALPRAZOLAM 214 133 39 31
CARVEDILOL 212 161 40 20
FENOFIBRATE 205 96 41 50
FLUTICASONE PROPIONATE 201 138 42 32
LANTUS 190 128 43 59
RANITIDINE HCL 187 113 44 29
PLAVIX 186 152 45 39
SERTRALINE HCL 176 101 46 27
TAMSULOSIN HCL 170 151 47 28
NIFEDIPINE ER 160 138 48 67
DOXAZOSIN MESYLATE 157 148 49 57
TRAZODONE HCL 157 70 49 64
ENALAPRIL MALEATE 156 126 51 35
GLYBURIDE 153 115 R 52 54
FOLIC ACID 146 122 53 95
CLONIDINE HCL 142 93 54 46
DIGOXIN 140 123 55 51
INSULIN SYRINGE 137 74 56 76
OXYCODONE HCL-ACETAMINOPHEN 137 43 S2 56 104
OXYCODONE-ACETAMINOPHEN 136 87 S2 58 91
BACLOFEN 129 78 59 97
ALLOPURINOL 126 86 60 37
ADVAIR DISKUS 123 79 61 52
BUMETANIDE 121 95 62 134
AZITHROMYCIN 117 53 63 34
NAPROXEN 116 61 64 70
GEMFIBROZIL 115 57 65 82
PIROXICAM 114 83 66 402
CARISOPRODOL 111 39 R 67 115
LOSARTAN-HYDROCHLOROTHIAZIDE 106 85 68 48
TORSEMIDE 105 96 69 215
KLOR-CON M20 102 79 70 121
DIOVAN 100 75 71 40
MECLIZINE HCL 99 94 72 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 66 73 110
TEMAZEPAM 94 53 74 47
AMOXICILLIN 94 56 74 133
FAMOTIDINE 89 68 76 61
SPIRIVA 88 52 77 93
LYRICA 88 29 77 120
BETAMETHASONE DIPROPIONATE 85 61 79 311
NEXIUM 83 42 80 44
CHLORTHALIDONE 83 78 80 208
METFORMIN HCL ER 82 60 82 92
LANTUS SOLOSTAR 78 43 83 124
SPIRONOLACTONE 77 51 84 77
OXAPROZIN 76 54 85 490
FINASTERIDE 76 70 85 66
SYNTHROID 73 54 87 42
FLUCONAZOLE 71 35 88 226
AMOX TR-POTASSIUM CLAVULANATE 71 46 88 118
CYMBALTA 70 15 90 79
OXYBUTYNIN CHLORIDE 70 55 90 107
PROPRANOLOL HCL 70 38 90 156
KLOR-CON 10 69 59 93 106
GLIPIZIDE XL 63 55 94 190
LANSOPRAZOLE 62 46 95 116
CYCLOBENZAPRINE HCL 62 27 R 95 98
GLYBURIDE-METFORMIN HCL 61 61 R 97 94
NOVOLOG 61 27 97 123
HUMULIN 70-30 60 38 99 192
NIFEDIAC CC 60 45 99 325
PAROXETINE HCL 58 34 101 60
HYDRALAZINE HCL 57 35 102 81
AMLODIPINE BESYLATE-BENAZEPRIL 57 44 102 74
SINGULAIR 56 45 104 90
FLUOXETINE HCL 56 22 104 68
PRADAXA 55 43 106 258
DIOVAN HCT 54 49 107 80
CLOTRIMAZOLE-BETAMETHASONE 54 40 107 84
COMBIVENT 54 30 107 170
ETODOLAC 53 40 110 283
PENTOXIFYLLINE 52 44 111 180
PEN NEEDLE 52 30 111 166
PREMARIN 52 41 R 111 217
VENLAFAXINE HCL 51 16 114 272
QUETIAPINE FUMARATE 50 16 115 89
METRONIDAZOLE 50 30 115 247
HYDROXYZINE PAMOATE 50 28 R 115 416
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.